Chief Medical Officer

Compass Executives were engaged by VC-backed Amplo Biotechnology to source a Chief Medical Officer as part of a critical hire to further develop their first pre-clinical project.

As a newly formed Adeno-Associated Virus (AAV) specialist Biotechnology organisation, Compass Executives were engaged to offer both consultancy services in the form of salary benchmarking for a permanent headcount, whilst at the same time being able to offer executive search services to secure an interim CMO whilst a concurrent process was being run for the permanent headcount. Three suitable profiles were identified and presented to Amplo Biotechnology, of the three, one candidate stood-out and was on-boarded in a Consulting basis with a view of being made permanent after 3 months.